IFNG and cancer: Furthermore, emerging evidence from lung cancer research indicates that TRIM34 activation mediated by IFN-γ may effectively inhibit metastatic progression by compromising cancer cell migratory and invasive capacities (Chaudhari et al., 2024[17]).